319
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System

, , , , , , & show all
Pages 1171-1178 | Published online: 22 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shuan Tao, Huimin Chen, Na Li & Wei Liang. (2022) The Application of the CRISPR-Cas System in Antibiotic Resistance. Infection and Drug Resistance 15, pages 4155-4168.
Read now
Peisi Li, Peng Wan, Ruonan Zhao, Jin Chen, Xiaoshen Li, Jie Li, Wenguang Xiong & Zhenling Zeng. (2022) Targeted Elimination of blaNDM-5 Gene in Escherichia coli by Conjugative CRISPR-Cas9 System. Infection and Drug Resistance 15, pages 1707-1716.
Read now

Articles from other publishers (14)

Mohammad Abavisani, Reza Khayami, Melika Hoseinzadeh, Mansoor Kodori, Prashant Kesharwani & Amirhossein Sahebkar. (2023) CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resistance Updates 68, pages 100948.
Crossref
Qi Li, Mingjun Sun, Lu Lv, Yong Zuo, Suyi Zhang, Ying Zhang & Sheng Yang. (2023) Improving the Editing Efficiency of CRISPR-Cas9 by Reducing the Generation of Escapers Based on the Surviving Mechanism. ACS Synthetic Biology 12:3, pages 672-680.
Crossref
Khushal Khambhati, Gargi Bhattacharjee, Nisarg Gohil, Gurneet K. Dhanoa, Antonia P. Sagona, Indra Mani, Nhat Le Bui, Dinh‐Toi Chu, Janardhan Keshav Karapurkar, Su Hwa Jang, Hee Yong Chung, Rupesh Maurya, Khalid J. Alzahrani, Suresh Ramakrishna & Vijai Singh. (2022) Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens . Bioengineering & Translational Medicine 8:2.
Crossref
Rajeshwari Kundar & Karuna Gokarn. (2022) CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria. Pharmaceuticals 15:12, pages 1498.
Crossref
Shuang Lu, Ting Tao, Yating Su, Jia Hu, Li Zhang, Guoliang Wang, Xiangyu Li & Xiaohua Guo. (2022) Whole Genome Sequencing and CRISPR/Cas9 Gene Editing of Enterotoxigenic Escherichia coli BE311 for Fluorescence Labeling and Enterotoxin Analyses. International Journal of Molecular Sciences 23:14, pages 7502.
Crossref
Priyanka Ashwath & Akhila Dharnappa Sannejal. (2022) A Quest to the Therapeutic Arsenal: Novel Strategies to Combat Multidrug- resistant Bacteria. Current Gene Therapy 22:2, pages 79-88.
Crossref
Chunye Zhang & Ming Yang. (2022) Antimicrobial Peptides: From Design to Clinical Application. Antibiotics 11:3, pages 349.
Crossref
Geetanjali M. Litake. 2022. Antimicrobial Resistance. Antimicrobial Resistance 559 575 .
Pragya Tiwari, Yashdeep Srivastava & Vinay Kumar. 2022. Antimicrobial Resistance. Antimicrobial Resistance 289 322 .
Yuye Wu, Dheerendranath Battalapalli, Mohammed J. Hakeem, Venkatarao Selamneni, Pengfei Zhang, Mohamed S. Draz & Zhi Ruan. (2021) Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. Journal of Nanobiotechnology 19:1.
Crossref
Yu-Zhang He, Jin-Ru Yan, Bing He, Hao Ren, Xu Kuang, Teng-Fei Long, Cai-Ping Chen, Xiao-Ping Liao, Ya-Hong Liu & Jian Sun. (2021) A Transposon-Associated CRISPR/Cas9 System Specifically Eliminates both Chromosomal and Plasmid-Borne mcr-1 in Escherichia coli . Antimicrobial Agents and Chemotherapy 65:10.
Crossref
Marco Aurelio Vianello, Brenda Cardoso, Danny Fuentes-Castillo, Quézia Moura, Fernanda Esposito, Bruna Fuga, Nilton Lincopan & Eryvaldo Sócrates T. Egito. (2021) International high-risk clone of fluoroquinolone-resistant Escherichia coli O15:H1-D-ST393 in remote communities of Brazilian Amazon. Infection, Genetics and Evolution 91, pages 104808.
Crossref
Manuel González de Aledo, Mónica González-Bardanca, Lucía Blasco, Olga Pacios, Inés Bleriot, Laura Fernández-García, Melisa Fernández-Quejo, María López, Germán Bou & María Tomás. (2021) CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies. Antibiotics 10:7, pages 756.
Crossref
Osmond C. Ekwebelem, Job Aleke, Ekenedirichukwu Ofielu & Obinna Nnorom-Dike. (2021) CRISPR-Cas9 System: A Revolutionary Tool in the Fight Against Antimicrobial Resistance: Retracted. Infectious Microbes and Diseases 3:2, pages 51-56.
Crossref